一位了解 DeepMind 内情的人士透露，这些变化是为了鼓励研究人员投身于短期来看对战略或者竞争优势无益的工作。他们还补充称，DeepMind 每年仍会发表数百篇论文，并且是各大 AI 顶会的领先贡献者之一。

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Isomorphic Labs was spun out of Google DeepMind, after the tech giant achieved one of the biggest biological breakthroughs in ...

金融时报消息，总部位于英国伦敦的 Isomorphic Labs 宣布完成6 亿美元融资。本次由 Thrive Capital 领投，现有投资者G谷歌的母公司Alphabet、GV也进行了追加投资。这笔资金将用于进一步开发其人工智能驱动的药物设计技术 ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Demis Hassabis, cofounder of DeepMind and 2024 ... AlphaFold’s success would pave the way for Isomorphic Labs, a spinoff focused on AI-driven drug discovery. Isomorphic was founded in 2021, ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.